Gpr37 modulates the severity of inflammation-induced GI dysmotility by regulating enteric reactive gliosis

Related articles

1. A20 inhibites intestinal mucosal permeability of IBS-D rats by regulating STAT3 signaling pathway

   This article has 8 authors:

   1. Jiaman Lin
   2. Yongquan Huang
   3. Zefang Yang
   4. Xiling Yang
   5. Jiahe Zhang
   6. Danting Shen
   7. Caiyan Wang
   8. Qiuke Hou

2. Ellagic Acid as a Natural Product-Based GPR35 Agonist for Ulcerative Colitis

   This article has 8 authors:

   1. Haichao Liu
   2. Le Yang
   3. Xiaoxu Ma
   4. Guanying Wang
   5. Dongxue Wang
   6. Xiaokang Liu
   7. Zhenwei Li
   8. Dean Guo

3. Treatment of Inflammatory Bowel Disease with Drugs Targeting PANoptosis: A Comprehensive Review

   This article has 2 authors:

   1. John K. Triantafillidis
   2. Stavros Karakatsanis